Personalized Therapeutics for K_ATP-Dependent Pathologies

Keyphrases

• SUR1 100%
• Personalized Therapy 100%
• Effective Treatment 50%
• Monogenic 50%
• Multiple Tissues 50%
• Gain-of-function mutation 50%
• Pore-forming Subunit 50%
• KATP Channel 50%
• Therapeutic Agents 50%
• Electrical Activity 50%
• ATP-sensitive Potassium Channel 50%
• Pharmacology 50%
• Selective Channels 50%
• Cross-reactivity 50%
• Cellular Metabolism 50%
• Receptor Subunits 50%
• Channel Inhibitor 50%
• Inhibitor Drug 50%
• Drug-induced 50%
• Channel Openers 50%
• Armoury 50%

Medicine and Dentistry

• Adenosine Triphosphate Sensitive Potassium Channel 100%
• Sulfonylurea Receptor 100%
• Loss of Function Mutation 50%
• Adenosine Triphosphate 50%
• Therapeutic Agent 50%
• Channel Opener 50%
• Cell Metabolism 50%
• Receptor Subunit 50%
• Cross Reaction 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Sulfonylurea Receptor 100%
• Adenosine Triphosphate Sensitive Potassium Channel 100%
• Adenosine Triphosphate 50%
• Isotopes of Potassium 50%
• Receptor Subunit 50%
• Channel Opener 50%